Fig. 1

Acteoside inhibits cell proliferation in HCC cells. The three human HCC cell lines BEL7404 (a), HLF (b) and JHH (c) were treated with different doses of acteoside (3, 10, 30, 100, 300 and 1000 μM) following an overnight attachment in 96-well plates. Cell proliferation was detected with MTT at 24 h, 48 h and 72 h post-treatment. Each treatment was performed in triplicate. The dose-response curve was fitted with nonlinear regression